Overall, 313 individuals had ER negative breast cancer, and 1,036 individuals had ER positive; 647 individuals had PR negative and 702 individuals had PR positive; 1,181 individuals with Her-2 negative, and 168 individuals had Her-2 positive breast cancer. The gene discussed is ESR1; the disease is breast carcinoma.